Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172105 | SCV000055143 | uncertain significance | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000151873 | SCV000200357 | uncertain significance | not specified | 2013-10-18 | criteria provided, single submitter | clinical testing | The Arg165Gln variant in SGCD has not been previously reported in individuals wi th cardiomyopathy or in large European American or African American cohorts. Com putational analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. Additional information is needed to fully assess the clinical signi ficance of the Arg165Gln variant. |
Eurofins Ntd Llc |
RCV000172105 | SCV000342535 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000515330 | SCV000611434 | uncertain significance | Dilated cardiomyopathy 1L; Autosomal recessive limb-girdle muscular dystrophy type 2F | 2021-08-03 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000151873 | SCV000740669 | uncertain significance | not specified | 2016-05-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000515330 | SCV000789697 | uncertain significance | Dilated cardiomyopathy 1L; Autosomal recessive limb-girdle muscular dystrophy type 2F | 2017-02-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000700991 | SCV000829771 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 165 of the SGCD protein (p.Arg165Gln). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with SGCD-related conditions. ClinVar contains an entry for this variant (Variation ID: 165234). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SGCD protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000172105 | SCV001811391 | uncertain significance | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | Reported as a maternally inherited variant in siblings with gastroschisis (PMID: 32163230); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23861362, 32163230) |
Genome- |
RCV000700991 | SCV003931859 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2F | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233117 | SCV003931860 | uncertain significance | Dilated cardiomyopathy 1L | 2023-02-08 | criteria provided, single submitter | clinical testing |